4 completed, 2 terminated, 2 unknown, 1 recruiting. 5 Not applicable, 2 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 5 | Completed 3, Recruiting 1, Unknown 1 |
| Phase 2 | 2 | Terminated 1, Unknown 1 |
| Phase 3 | 2 | Completed 1, Terminated 1 |
Follow hAM: new trials by email Literature Review of hAM trials Research Report on hAM
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| hAM for Inferior RRD hAM - Rhegmatogenous Retinal Detachment | Not applicable | Recruiting | Eye & ENT Hospital of Fudan University | 50 | 2025-08-01 | 2025-07-28 |
| Human Amniotic Membrane (hAM) for Stage II Maxillomandibular Osteonecrosis Management Human Amniotic Membrane, Conventional/Standard treatment - Osteonecrosis Due to Drugs, Jaw | Phase 2 | Unknown | Centre Hospitalier Universitaire de Besancon | 66 | 2023-09-22 | 2024-09-19 |
| Surgical Management of Stage-2 MRONJ With Transplantation of HAM HAM - Medication Related Osteonecrosis of the Jaw, Oral Surgery | Not applicable | Completed | Trakya University | 14 | 2020-01-15 | 2025-04-13 |
| Efficacy/Safety of CPI-613 in Combination With HD Cyt. and Mito. vs HD Cyt. and Mito. in Older Patients With R/R AML CPI-613 + High Dose Cytarabine and Mitoxantrone, High Dose Cytarabine and Mitoxantrone, Mitoxantrone, Etoposide and Cytarabine - Relapsed/Refractory Acute Myeloid Leukemia | Phase 3 | Terminated | Cornerstone Pharmaceuticals | 200 | 2018-11-12 | 2023-02-08 |
| Impact of Remission Induction Chemotherapy Prior to Allogeneic SCT in Relapsed and Poor-response Patients With AML HAM, LDAC and/or Mitoxantrone - Acute Myeloid Leukemia | Phase 3 | Completed | DKMS gemeinnützige GmbH | 281 | 2015-09-17 | 2024-01-19 |
| The Glycemic and Insulinemic Responses Elicited by Meals Containing Whole Grain Rye Bread or White Wheat Bread Wheat bread, margarine, ham - Blood Glucose Concentration | Not applicable | Unknown | University of Helsinki | 15 | 2015-03-01 | 2015-09-04 |
| Immunotherapy Study for Patients With Stage IV Melanoma HyperAcute®-Melanoma (HAM) Immunotherapy, Ipilimumab, Pembrolizumab - Stage IV Melanoma, Metastatic Melanoma | Phase 2 | Terminated | NewLink Genetics Corporation | 47 | 2014-06-01 | 2023-04-18 |
| Preventive Strategies in Colorectal Carcinogenesis Production and Meat Processing ham, ham + pomegranate extract, ham + tocopherol - Colorectal Cancer | Not applicable | Completed | Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement | 24 | 2014-04-01 | 2015-06-16 |
| Processed Meat and Colon Carcinogenesis Ham, Ham + calcium, Ham + vitamin E - Colorectal Cancer | Not applicable | Completed | Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement | 18 | 2009-10-01 | 2012-12-17 |
Colorectal Neoplasms (2) · Leukemia, Myeloid, Acute (2) · Insulin Resistance (1) · Melanoma (1)
Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement (2) · Centre Hospitalier Universitaire de Besancon (1) · Cornerstone Pharmaceuticals (1) · DKMS gemeinnützige GmbH (1) · Eye & ENT Hospital of Fudan University (1) · NewLink Genetics Corporation (1) · Trakya University (1) · University of Helsinki (1)
France (4) · Germany (2) · United States (2) · Australia (1) · Austria (1) · Belgium (1) · China (1) · Poland (1) · South Korea (1) · Spain (1) · Turkey (Türkiye) (1)
Eugene Kennedy, MD (1) · Fabrice Pierre, PhD (1) · Johannes Schetelig, Prof Dr med (1) · Jorge E Cortes, MD (1)
PMID 24025632, PMID 34563730, PMID 38583455, PMID 40454396, PMID 40737595
2014 (1)